Abstract
The contrast in X-ray images is typically produced by attenuation of the X-rays in the examined tissues or samples. Without contrast, only skeletal structures of sacrificed or live animals can be visualized in detail. The transit and accumulation of contrast media (CM) in different organs (enhancement) improve the differentiation of morphological structures, particularly between normal and pathological tissue.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Allen TM (1994) The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by mononuclear phagocyte system. Adv Drug Delivery Rev 13:285–309
Bakan DA, Doerr-Stevens JK, Weichert JP et al (2001) Imaging efficacy of a hepatocyte-selective polyiodinated triglyceride for contrast-enhanced computed tomography. Am J Ther 8:359–365
Cassel DM, Young SW, Brody WR et al (1982) Radiographic blood pool contrast agents for vascular and tumor imaging with projection radiography and computed tomography. J Comput Assist Tomogr 6(1):141–146
Choukèr A, Lizak M, Schimel D et al (2008) Comparison of Fenestra VC contrast-enhanced computed tomography imaging with gadopentetate dimeglumine and Ferucarbotran magnetic resonance imaging for the in vivo evaluation of murine liver damage after ischemia and reperfusion. Invest Radiol 43:77–91
Ford NL, Graham KC, Groom AC et al (2006) Time-course characterization of the computed tomography contrast enhancement of an iodinated blood-pool contrast agent in mice using a volumetric flat-panel equipped computed tomography scanner. Invest Radiol 41(4):384–390
Graham KC, Ford NL, MacKenzie LT et al (2008) Noninvasive quantification of tumor volume in preclinical liver metastasis models using contrast-enhanced X-ray computed tomography. Invest Radiol 43:92–99
Hainfeld JF, Slatkin DN, Focella TM et al (2006) Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 79:248–253
Henning T, Weber AW, Bauer JS et al (2008) Imaging characteristics of DHOG, a hepatobiliary contrast agent for preclinical microCT in mice. Acta Radiol 15:342–349
Hughes PM, Bisset R (1991) Non-ionic contrast media: a comparison of iodine delivery rates during manual injection angiography. Br J Radiol 64(761):417–419
Koa C-Y, Hoffman EA, Beck KC et al (2003) Long-residence-time nano-scale liposomal iohexol for X-ray-based blood pool imaging. Acta Radiol 10:475–483
Kim SH, Park JH, Kim YI et al (1990) Experimental tissue damage after subcutaneous injection of water soluble contrast media. Invest Radiol 25:678–685
Krause W, Leike J, Sachse A et al (1993) Characterization of iopromide liposomes. Invest Radiol 28(11):1028–1032
Krause W (1994) Preclinical characterization of iopromide. Invest Radiol 29(1):S21–S32
Mützel W, Speck U, Weinmann H-J (1983) Pharmacokinetics of iopromide in rat and dog. In: Taenzer V, Zeitler E (eds) Contrast media in urography, angiography and computed tomography. Thieme, Stuttgart, pp 85–90
Poste G (1983) Liposome targeting in vivo: problems and opportunities. Biol Cell 47:19–38
Rabin O, Perez JM, Grimm et al (2006) An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater 5(2):118–122
Rau T, Mathey D, Schofer J (1997) High-dose tolerance of iodinated x-ray contrast media. New developments in x-ray and MR angiography symposium CIRSE, 9.9.96, Funchal, Madeira. Cardiovasc Intervent Radiol 20:8–9
Rosovsky M, Rusinek H, Berenstein A et al (1996) High-dose administration of non-ionic contrast media: a retrospective review. Radiology 200:119–122
Sachse A, Leike JU, Schneider T et al (1997) Biodistribution and computed tomography blood-pool imaging properties of polyethylene glycol-coated iopromide-carrying. Invest Radiol 32(1):44–50
Seltzer SE, Gregoriadis G, Dick R (1988) Evaluation of the dehydration-rehydration method for production of contrast-carrying liposomes. Invest Radiol 23(2):131–138
Senior JH (1987) Fate and behaviour of liposomes in vivo: a review of controlling factors. Critic Rev Ther Drug Carrier Syst 3:123–193
Schmiedl UP, Krause W, Leike J et al (1999) CT blood pool enhancement in primates with iopromide-carrying liposomes containing soy phosphatidyl glycerol. Acad Radiol 6:164–169
Torchilin VP, Frank-Kamenetsky MD, Wolf GL (1999) CT visualization of blood pool in rats by using long-circulating, iodine-containing micelles. Acad Radiol 6:61–65
Vera DR, Mattrey RF (2002) A molecular CT blood pool contrast agent. Acad Radiol 9:784–792
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Pietsch, H. (2011). CT Contrast Agents. In: Kiessling, F., Pichler, B. (eds) Small Animal Imaging. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-12945-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-12945-2_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-12944-5
Online ISBN: 978-3-642-12945-2
eBook Packages: MedicineMedicine (R0)